Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.
Semiphysiologically based pharmacokinetic model for the midazolam and the CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.